步长制药：第五届监事会第七次会议决议公告

Core Viewpoint - The company, Buchang Pharma, announced the approval of several proposals, including the 2025 semi-annual report and summary, during the seventh meeting of its fifth supervisory board [2] Group 1 - The supervisory board meeting was held on August 27, where multiple proposals were reviewed and approved [2]